Last reviewed · How we verify

NCT03541590

Ultrasound-guided Percutaneous Biliary Drainage With Primary Metal Implantation by Endoscopic Luminal Guidance

Completed Last updated 30 May 2018
What this trial tests

trial testing Percutaneous transhepatic biliary drainage in Bile Duct Obstruction, Extrahepatic in 66 participants. Completed in 31 December 2017.

Timeline
1 December 2008
Primary endpoint
30 October 2017
31 December 2017

Quick facts

Lead sponsorTheresienkrankenhaus und St. Hedwig-Klinik GmbH
StatusCompleted
Study typeOBSERVATIONAL
Enrollment66
Start date1 December 2008
Primary completion30 October 2017
Estimated completion31 December 2017
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Theresienkrankenhaus und St. Hedwig-Klinik GmbH — full company profile →

Who can join

18 and older, any sex, with Bile Duct Obstruction, Extrahepatic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In a recently published meta-analysis (Sharaiha, Gastrointestinal Endoscopy, 2017), it is reported that percutaneous transhepatic biliary drainage (PTBD) is less clinical successful, causes more adverse events and needs more re-interventions than endoscopic ultrasound guided biliary drainage (EUBD) in patients with malignant, extrahepatic bile duct obstruction. The conclusion was, that EUBD should be prefered in this clinical setting in future. An improved technique of PTBD may provide better results for coming comparative studies. The investigators of this retrospective study therefore analyzed all PTBDs that were performed in a period of nine years in a tertiary referral hospital. In this cohort, the analysis focused on PTBDs with primary metal stent implantation by endoscopic luminal guidance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Percutaneous transhepatic biliary drainage

Trials testing the same drug.

Other Theresienkrankenhaus und St. Hedwig-Klinik GmbH trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03541590.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing